Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

K. Armstrong, Deborah; N. Bundy, Brian; Wenzel, Lari; Huang, Helen; N. Baergen, Rebecca; Lele, Shashikant; J. Copeland, Larry; L. Walker, Joan; A. Burger, Robert

doi:10.1056/nejmoa052985

Public

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

Published in New England Journal of Medicine • Jan 4, 2006

Authors:

Deborah K. Armstrong

Brian N. Bundy

Lari Wenzel

Abstract

BACKGROUND: Standard chemotherapy for newly diagnosed ovarian cancer is a platinum-taxane combination. The Gynecologic Oncology Group conducted a randomized, phase 3 trial that compared intravenous paclitaxel plus cisplatin with intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel in...

Subject

Medicine

Cisplatin

Gynecologic oncology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!